You are here: Home » Current Affairs » News » National
Business Standard

Bill Gates hails India for scientific innovation, Covid vaccine production

US business magnate, philanthropist, and co-founder of Microsoft Bill Gates on Tuesday applauded India's effort in the fight against the Covid-19 pandemic

Bill Gates | Bill Gates on India | Coronavirus Vaccine

ANI  |  Asia 

Bill Gates
Bill Gates

US business magnate, philanthropist, and co-founder of on Tuesday applauded India's effort in the fight against the Covid-19 pandemic.

He also hailed India's leadership in scientific innovation and vaccine manufacturing capability.

"It's great to see India's leadership in scientific innovation and vaccine manufacturing capability as the world works to end the COVID-19 pandemic," he tweeted, tagging PMO India in the post.

The founder had previously written to PM Modi hailing the Indian government's utilisation of "its exceptional digital capabilities in its COVID-19 response and launched the Aarogya Setu digital app for tracking, contact tracing, and to connect people to health services."

"We commend your leadership and the proactive measures you and your government have taken to flatten the curve of the COVID-19 infection rate in India, such as adopting a lockdown, expanding focused testing to identify hot spots for isolation, quarantining, and care, and significantly increasing health expenditures to strengthen the health system response and promote R & D and digital innovation," Gates had written in April 2020.

Meanwhile, earlier today Director-General of the World Health Organisation (WHO)

Tedros Adhanom Ghebreyesus also lauded India's action and its resolve to end the Covid-19 pandemic as the largest vaccine producer of the world. Lauding the efforts of PM Modi in the fight against the pandemic, he wrote, "If we #ACTogether, we can ensure effective & safe vaccines are used to protect the most vulnerable everywhere @narendramodi".

On Monday, PM Modi pointed out that the world's largest Covid-19 vaccination programme is also going to start in India and that the CSIR and other institutions are working together came together to face every challenge and find solutions for new situations.

"For this, the country is very proud of the contribution of its scientists. Today is also the day to remember the time when our scientific institutions, all of you, worked day and night together to develop the vaccine to defeat Covid," he added.

Speaking at the inauguration of Atomic Timescale and Bhartiya Nirdeshak Dravya, via video conferencing on Monday, PM Modi said, "Indian scientists have been successful in coming up with two 'Made in India' COVID19 vaccines. The country is proud of its scientists," he added.

India has one of the largest vaccine manufacturing capacities in the world (including the largest vaccine producer - Serum Institute of India) and has secured authorisation to mass-produce the AstraZeneca, Novavax and Gamaleya Research Institute vaccines.

With a population of 1.3 billion (and 94 million over 65-year-olds), the domestic vaccination drive will be the largest in the world.

The country has a good track record of such drives with masses of the population regularly gaining inoculation for various diseases such as polio and cholera.

India's vaccine rollout will begin with frontline healthcare workers and individuals over the age of 50 years gaining priority. The government aims to vaccinate some 250 million people over six-to-eight months.

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

Dear Reader,

Business Standard has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and have wider political and economic implications for the country and the world. Your encouragement and constant feedback on how to improve our offering have only made our resolve and commitment to these ideals stronger. Even during these difficult times arising out of Covid-19, we continue to remain committed to keeping you informed and updated with credible news, authoritative views and incisive commentary on topical issues of relevance.
We, however, have a request.

As we battle the economic impact of the pandemic, we need your support even more, so that we can continue to offer you more quality content. Our subscription model has seen an encouraging response from many of you, who have subscribed to our online content. More subscription to our online content can only help us achieve the goals of offering you even better and more relevant content. We believe in free, fair and credible journalism. Your support through more subscriptions can help us practise the journalism to which we are committed.

Support quality journalism and subscribe to Business Standard.

Digital Editor

First Published: Tue, January 05 2021. 11:50 IST